Definitive Healthcare Corp.

DH • Medical - Healthcare Information Services

$1.13

▲ +0.03 (+2.73%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$120.62M

Crecimiento

25.7%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Crecimiento positivo de ingresos · 7.2%Flujo de caja libre positivo · 0.35Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.63Liquidez saludable · 1.64

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 12 ago 2026, 12:28 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$1.13

Change2.73%

Shares Out105.81M

Market Cap$120.62M

Enterprise Value$-56.55M

52W Range0.62 - 4.35

Beta1.34

P/E-0.72

P/S0.52

P/B0.64

P/FCF4.22

EV/Sales-0.24

Price$1.13

Change2.73%

Shares Out105.81M

Market Cap$120.62M

Enterprise Value$-56.55M

52W Range0.62 - 4.35

Beta1.34

P/E-0.72

P/S0.52

P/B0.64

P/FCF4.22

EV/Sales-0.24

EV/EBITDA-10.93

EV/FCF-1.98

Earnings Yield-139.44%

FCF Yield23.68%

Dividend Yield0.27%

Gross Margin75.88%

Oper. Margin-8.52%

Profit Margin-57.52%

Debt/Eq0.63

Current Ratio1.64

Quick Ratio1.64

Revenue 5Y25.72%

FCF 5Y17.49%

Target$1.20

Target Upside6.19%

Target Median$1.10

Target Range1.00 - 1.50

Volume357.53K

Avg Volume337.54K

EPS Surprise0.03

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

22/100

Fortaleza financiera

Deuda, caja, estabilidad

69/100

Potencial de crecimiento

Ingresos y expansión

88/100

Atractivo del precio

Barata o cara hoy

94/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 7.2%Flujo de caja libre positivo · 0.35Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.63Liquidez saludable · 1.64Rentabilidad débil

Analyst view

Analyst sentiment and price target

Analyst sentiment

Based on 15 analyst votes · 2026-10-20

50/100

Neutral

Bullish

Hold

Bearish

Precio objetivo

2026-08-12

Bajo

$1.10

Promedio

$1.30

Mediana

$1.30

Alto

$1.50

Resumen de la compañía

IPO: 9/15/2021

Industria: Medical - Healthcare Information Services

P/B i: 0.64

Deuda / Patrimonio i: 0.63

Margen operativo: -8.52%

Margen neto: -57.52%

ROE i: -

ROIC: -

Salud financiera

Puntaje14 / 20

Deuda / Patrimonio: 0.63

Ratio corriente: 1.64

Ratio rápido: 1.64

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

⚠ 1 venta interna de alto volumen detectada

Heller Casey

Transacción: 08/01/2026

VENTA

Cambio

-1,881

Precio

$0.68

Presentación

08/04/2026

Tipo

VENTA

Krantz Jason Ronald

Transacción: 08/01/2026

VENTA

Cambio

-12,166

Precio

$0.68

Presentación

08/04/2026

Tipo

VENTA

Paris Jonathan

Transacción: 07/01/2026

VENTA

Cambio

-30,591

Precio

$0.80

Presentación

07/06/2026

Tipo

VENTA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Heller Casey	VENTA	-1,881	$0.68	08/01/2026	08/04/2026
Krantz Jason Ronald	VENTA	-12,166	$0.68	08/01/2026	08/04/2026
Paris Jonathan	VENTA	-30,591	$0.80	07/01/2026	07/06/2026
Coop Kevin	VENTA	-37,593	$0.80	07/01/2026	07/06/2026
Hamood Samuel A	COMPRA	+189,190	Not reported	06/04/2026	06/09/2026
Chilukuri Sastry	COMPRA	+189,190	Not reported	06/04/2026	06/08/2026
Winters Kathleen A	COMPRA	+189,190	Not reported	06/04/2026	06/08/2026
Stephenson Scott G	COMPRA	+189,190	Not reported	06/04/2026	06/08/2026
Heller Casey	VENTA	-1,469	$0.99	05/01/2026	05/05/2026
Krantz Jason Ronald	VENTA	-12,166	$0.99	05/01/2026	05/05/2026
Krantz Jason Ronald	VENTA	-45,154	$1.09	04/01/2026	04/03/2026
Coop Kevin	VENTA	-37,593	$1.09	04/01/2026	04/03/2026
Coop Kevin	VENTA	-175,524	$1.28	03/01/2026	03/03/2026
Krantz Jason Ronald	COMPRA	+242,719	Not reported	02/24/2026	02/26/2026
Coop Kevin	COMPRA	+1,735,437	Not reported	02/24/2026	02/26/2026
Heller Casey	COMPRA	+733,301	Not reported	02/24/2026	02/26/2026
Paris Jonathan	COMPRA	+481,505	Not reported	02/24/2026	02/26/2026
Graboske Benjamin	OTRO	0	Not reported	02/24/2026	02/26/2026
Heller Casey	VENTA	-1,469	$2.32	02/01/2026	02/03/2026
Krantz Jason Ronald	VENTA	-44,545	$2.32	02/01/2026	02/03/2026

Sobre la compañía

Definitive Healthcare Corp.

Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.

Fuente - Link

Competidores

CABA EDIT KYTX NAKA NRC OMI SLP SOPH SPOK TBRG

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial Comparison

Definitive Healthcare (NASDAQ: DH - Get Free Report) and Firefly Neuroscience (NASDAQ: AIFF - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Profitability This table compares Definitive Healthcare and

Defense World

Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing

Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety

GlobeNewsWire

Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)

HealthStream (NASDAQ: HSTM - Get Free Report) and Definitive Healthcare (NASDAQ: DH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Earnings and Valuation This table compares HealthStream and

Defense World

Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outstanding shares of the Company's Class A common stock (the “Class A Common Stock”) and all of the outstanding limited liability company interests of AIDH TopCo, LLC (the “Definitive OpCo Units”), in each case, that are not already owned by Advent or Jason Krantz, the Company's founder and Executive Chairman, for an all-cash purchase price of $1.02 per share of Class A common stock, and an equivalent amount per Definitive OpCo Unit.

GlobeNewsWire

Definitive Healthcare Appoints Clay Ritchey as CEO

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026.

GlobeNewsWire

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-07	0.03	0.06	0.03
2026-02-26	0.06	0.06	0
2025-11-06	0.06	0.07	0.01
2025-08-07	0.05	0.07	0.02
2025-05-08	0.02	0.05	0.03
2025-02-27	0.07	0.08	0.01
2024-11-07	0.08	0.1	0.02
2024-08-05	0.09	0.09	0
2024-05-07	0.08	0.08	0
2024-02-28	0.07	0.07	0
2023-11-02	0.06	0.09	0.03
2023-08-14	0.05	0.08	0.03